Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors. [electronic resource]

By: Contributor(s): Producer: 20150627Description: 38 p. digitalISSN:
  • 2191-219X
Online resources: In: EJNMMI research vol. 4
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.